Das lnverkehrbringen von Arzneimitteln mit neuen Wirkstoffen ist in der Bundesrepublik Deutschland mit besonderen Auflagen f\u00fcr einen Zeitraum von mindestens f\u00fcnf Jahren – abgesehen von wenigen begr\u00fcndeten Ausnahmen – nach erstmaliger Zulassung verbunden. Diese Arzneimittel unterliegen einer f\u00fcnfj\u00e4hrigen automatischen Verschreibungspflicht. Nach der erstmaligen Zulassung sind dem Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) vom pharmazeutischen Unternehmer […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Das lnverkehrbringen von Arzneimitteln mit neuen Wirkstoffen ist in der Bundesrepublik Deutschland mit besonderen Auflagen f\u00fcr einen Zeitraum von mindestens f\u00fcnf Jahren – abgesehen von wenigen begr\u00fcndeten Ausnahmen – nach erstmaliger Zulassung verbunden. Diese Arzneimittel unterliegen einer f\u00fcnfj\u00e4hrigen automatischen Verschreibungspflicht. Nach der erstmaligen Zulassung sind dem Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) vom pharmazeutischen Unternehmer […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[189,130,386,396,387,316,309,312,314,313,315,389,255,317,320,311,307,319,310,399,395,388,397,188,398,394,392,393,391,390,270,413,410,124,49,402,404,415,414,412,257,408,406,409,401,407,403,400,405,157,411,370,367,372,120,376,371,369,119,306,381,378,375,384,377,382,385,380,383,234,373,365,374,368,366,379],"class_list":["post-406","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-2-chlordesoxyadenosin","tag-ace-hemmer","tag-alendronat","tag-all-trans-retinoinsaeure","tag-anastrozol","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-aromatasehemmer","tag-arzneimittel","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-atra","tag-bicalutamid","tag-cisatracurium","tag-citalopram","tag-cladribin","tag-doxazosin","tag-eptacog-alfa","tag-etoposid","tag-fludarabin","tag-fluvoxamin","tag-follitropin-beta","tag-gemcitabin","tag-glimepirid","tag-ibandronsaeure","tag-indinavir","tag-insulin-lispro","tag-iobitridol","tag-lamivudin","tag-levonorgestrel","tag-lodoxamid","tag-loperamidoxid","tag-medikamente","tag-meloxicam","tag-mivacurium","tag-mycophenolat","tag-nadroparin","tag-nebivolol","tag-nikotin","tag-nilutamid","tag-olanzapin","tag-orale-antidiabetika","tag-penciclovir","tag-ramipril","tag-remifentanil","tag-reteplase","tag-ritonavir","tag-ropinirol","tag-ropivacain","tag-rpa","tag-saquinavir","tag-sartane","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-sertralin","tag-sparfloxacin","tag-ssri","tag-stavudin","tag-tacalcitol","tag-tamsulosin","tag-tazaroten","tag-tiagabin","tag-tiludronsaeure","tag-topotecan","tag-toremifen","tag-tretinoin","tag-valsartan","tag-venlafaxin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=406"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/406\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}